Z. Du and X. Ma, “Dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin treatment for stage II-IV ovarian cancer patients”, Bangladesh J Pharmacol, vol. 10, no. 3, pp. 489–493, Jul. 2015.